Breaking News
June 19, 2018 - High blood pressure could be an early sign of dementia
June 19, 2018 - Innovative drugs and new European treatment guidelines refine, improve MS therapy
June 19, 2018 - BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure
June 19, 2018 - Diabetes diagnosis may come with increased risk of pancreatic cancer for African-Americans, Latinos
June 19, 2018 - Personalized Goals, Cash Motivate Heart Patients to Exercise
June 19, 2018 - Nipah Virus (NiV) | CDC
June 19, 2018 - Genomics offers new treatment options for infants with range of soft tissue tumors
June 18, 2018 - Study shows how moderate consumption of alcohol can protect the heart
June 18, 2018 - Gene editing technology predicts heart disease risk
June 18, 2018 - Who Will and Who Won’t Get the Flu?
June 18, 2018 - Research shows effective responses to online feedback
June 18, 2018 - Scientists to focus on big data and genetics to identify risk factors for dementia
June 18, 2018 - Ultrasound-based technology for assessing overweight adolescents with liver disease
June 18, 2018 - Osteochondral knee defect treated using cell technology
June 18, 2018 - Study demonstrates increased levels of gum disease in people at risk of rheumatoid arthritis
June 18, 2018 - Ebola & Marburg | NIH: National Institute of Allergy and Infectious Diseases
June 18, 2018 - Brains, eyes, testes: off-limits for transplants?
June 18, 2018 - Drug used to treat myelofibrosis can awaken ‘dormant’ lymphomas in the bone marrow
June 18, 2018 - New study focuses on best, cost effective practices to bridge treatment gap for brain disorders
June 18, 2018 - New study highlights predictors that prevent from achieving remission in early RA
June 18, 2018 - Neuroscientists map feeling of cool touch to the brain’s insula in mouse model
June 18, 2018 - Study highlights potential use of blood biomarkers as diagnostic tool for sleep apnea
June 18, 2018 - Eating plant-based diet can reduce risk for heart problems in people with type 2 diabetes
June 18, 2018 - Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis
June 18, 2018 - Study shows link between risky opioid prescriptions and increased odds of death
June 18, 2018 - Bone density scans could help determine likelihood of cardiovascular disease
June 18, 2018 - Mechanical thrombectomy appears to be important therapy for acute stroke in very old patients
June 18, 2018 - Novel compound as effective as FDA-approved antibiotics for treating deadly infections
June 18, 2018 - Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease
June 18, 2018 - Surgical outcomes equivalent whether physician anesthesiologist assisted by nurse anesthetist or AA
June 18, 2018 - Studies provide insight into molecular changes prior to onset of arthritis
June 18, 2018 - Dyaco unveils specialist medical and rehabilitation equipment range in the UK
June 18, 2018 - Engineers develop algorithm to monitor joints of patients with arthritis
June 18, 2018 - Women with higher vitamin D blood levels have lower risk for breast cancer
June 18, 2018 - New studies help elucidate role of sleep in chronic pain
June 18, 2018 - Researchers link red meat sensitivity spread by ticks with heart disease
June 18, 2018 - Research explores role of autopsy in cardiovascular medicine
June 18, 2018 - Motif Bio Submits NDA for Iclaprim
June 18, 2018 - NIH-funded researchers identify target for chikungunya treatment
June 18, 2018 - Negative emotions are murkier, less distinct in adolescence
June 18, 2018 - Gut microbiome may be potential contributor to depression, anxiety in people with obesity
June 18, 2018 - Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows
June 18, 2018 - What Does the Future Hold?
June 18, 2018 - FDA Approves Keytruda (pembrolizumab) for Treatment of Refractory or Relapsed Primary Mediastinal Large B-Cell Lymphoma (PMBCL)
June 18, 2018 - School cliques don’t always click
June 18, 2018 - Three experts from The Tinnitus Clinic contribute to major review on pulsatile tinnitus
June 18, 2018 - Unwieldy health costs often stand between teachers and fatter paychecks
June 18, 2018 - Link between frailty and mortality remains unchanged despite lower death rates, study finds
June 18, 2018 - Sleep disorders appear to be first sign of serious neurological diseases
June 18, 2018 - Childhood, adult obesity raise risk of developing hip and knee osteoarthritis
June 18, 2018 - Study unravels ‘blood stem cell niche’ puzzle
June 18, 2018 - People with heart problems do not take enough exercise, shows study
June 18, 2018 - Strong Link Identified Between T2DM and Parkinson’s Disease
June 18, 2018 - Early childhood interventions show mixed results on child development
June 18, 2018 - Chronic use of opioids related to increased risk of fracture nonunion
June 18, 2018 - AHA: Family Perseveres After Losing Father to Heart Attack
June 18, 2018 - Oral propranolol seems safe for infantile hemangioma
June 18, 2018 - New study gives explanation for food’s prominence in memory
June 18, 2018 - First photoactive drug to fight Parkinson’s disease
June 18, 2018 - Patient’s self-evaluation of personality disorders not as far off as previously perceived
June 18, 2018 - Upadacitinib Monotherapy Meets All Primary and Ranked Secondary Endpoints Versus Methotrexate in a Phase 3 Study in Rheumatoid Arthritis
June 18, 2018 - Vitamin B3 has a positive effect on damaged nerve cells in Parkinson’s patients
June 17, 2018 - Sunovion Announces FDA Acceptance of New Drug Application for Apomorphine Sublingual Film (APL-130277)
June 17, 2018 - Bid to beat obesity focuses on fat that keeps us warm
June 17, 2018 - Work Stress May Increase Risk of Developing Atrial Fibrillation
June 17, 2018 - New Zealand’s secret recipe for active school travel: The neighborhood built environment
June 17, 2018 - New Medscape report reveals sexual harassment rate of physicians
June 17, 2018 - Surgical Blood Transfusions Tied to Clot Risk
June 17, 2018 - CDC chief makes $375K, far exceeding his predecessors’ pay
June 17, 2018 - Education linked to higher risk of short-sightedness
June 17, 2018 - Patients with Moderate-to-Severe Ulcerative Colitis Achieved Clinical and Endoscopic Remission with Mirikizumab in Phase 2 Trial
June 17, 2018 - UA registers a more customised multifocal lens to correct presbyopia
June 17, 2018 - U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Talazoparib for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation
June 17, 2018 - Vaginal estrogen tablets, moisturizers and placebo gel all can improve vaginal discomfort
June 17, 2018 - Addition of Bezafibrate Beneficial in Primary Biliary Cholangitis
June 17, 2018 - Radiation Therapy for Cancer – National Cancer Institute
June 17, 2018 - Technology could help pregnant women detect health complications
June 17, 2018 - Study finds drop in frequent use of ED after Affordable Care Act
June 17, 2018 - Do Antipsychotic Meds for Kids Raise Diabetes Risk?
June 17, 2018 - New light shed on mechanisms of paediatric epilepsy
Delays Raise Death Risk in Kids with Status Epilepticus

Delays Raise Death Risk in Kids with Status Epilepticus

image_pdfDownload PDFimage_print

Action Points

  • Delay of ≥10 minutes after seizure onset in first-line benzodiazepine treatment of pediatric patients with refractory convulsive status epilepticus (SE) is associated with adverse short-term outcomes, including death, more frequent use of continuous infusions, longer seizure duration, and more frequent hypotension.
  • Note that these findings may change the perception of acute seizure and SE treatment, converting it into an extremely time-sensitive emergency similar to stroke or other cardiovascular events.

Delayed first-line treatment of refractory convulsive status epilepticus (SE) led to a higher frequency of death, a 5-year observational study from the Pediatric Status Epilepticus Research Group found.

Pediatric patients who received first-line benzodiazepine treatment 10 minutes or more after SE onset had a much higher chance of death (adjusted OR 11.0), greater odds of receiving continuous infusion (adjusted OR 1.8), longer convulsive seizure durations (adjusted OR 2.6), and more frequent hypotension (adjusted OR 2.3), reported Tobias Loddenkemper, MD, director of Clinical Epilepsy Research at Boston Children’s Hospital. and colleagues.

First-line treatment delays also were linked to delays in administering second- and third-line treatments.

“These findings may change the perception of acute seizure and status epilepticus treatment, tentatively converting it into an extremely time-sensitive emergency that is similar to stroke or other cardiovascular events,” the team wrote online in JAMA Neurology.

“This is the first pediatric study on refractory convulsive SE that demonstrates a link between delayed treatment and poor outcomes and suggests that timely treatment may be a method to prevent or improve such outcomes,” commented Anup D. Patel, MD, section chief of Neurology at Nationwide Children’s Hospital in Columbus, OH, writing in an accompanying editorial.

“Status epilepticus is life threatening and affects a high percentage of children. Both short-term and long-term morbidity and mortality risks are present for children who experience SE. Methods to improve these outcomes are thus desperately needed.”

Current SE treatment protocols recommend that patients receive first-line treatment — a benzodiazepine — within 5 to 10 minutes of seizure onset. This usually is followed by a second-line treatment of a non-benzodiazepine anti-seizure medication 10 to 20 minutes later. If SE persists, patients may receive a third-line treatment — anesthetic agents by continuous infusion — within 30 to 70 minutes of seizure onset.

The rationale is to stop seizures quickly and reduce the risk of brain damage and other complications. Studies have shown that seizures usually last less than 10 minutes; seizures lasting longer often do not stop spontaneously.

While time to treatment has been associated independently with SE duration, the effects on other outcome measurements like death were unknown.

To discover how timing mattered, Loddenkemper et al performed an observational study of 218 children admitted with refractory convulsive SE to 11 pediatric tertiary hospitals in the United States from June 1, 2011, to July 31, 2016. Patients were stratified into two groups: those who received timely first-line benzodiazepine (i.e., given within less than 10 minutes of seizure onset); and those who received treatment within 10 or more minutes.

Patients were ages 1 month to 21 years, had focal or generalized convulsive epileptic seizures at onset, and had treatment failure with two or more anti-seizure medications or started continuous infusion for seizure control.

The median age of the group was 4, and 53.2% were male. Of the 218 patients studied, 33.9% received first-line benzodiazepine treatment in less than 10 minutes, and 66.1% received it in 10 minutes or more. In 63.8% of patients, refractory convulsive SE started in a pre-hospital setting.

The median time to first-line benzodiazepine treatment was 17 minutes; it was longer in the pre-hospital group than the in-hospital cohort (25 minutes versus 8 minutes). The median time to the first administration of non-benzodiazepine anti-seizure medications was 63 minutes — that, too, was longer for the pre-hospital group (82 minutes) than the in-hospital group (40 minutes).

During hospital admission, seven patients (3.2%) died. All seven received untimely first-line benzodiazepine treatment, and five of the seven had pre-hospital SE onset. Multivariate analysis showed that untimely first-line benzodiazepine treatment had an adjusted OR of death of 11.0 (95% CI 1.43 to ∞; P=0.02.).

About half of the patients in the study — 112, or 51.4% — received a continuous infusion; of these, 71.4% had received untimely first-line treatment (P=0.09). The untimely treatment group was more likely to receive one or more continuous infusions (adjusted OR, 1.8; 95% CI 1.01-3.36; P=0.047).

The median convulsion duration was 48.5 minutes longer for patients who received untimely first-line benzodiazepine treatment (91 versus 139.5 minutes; P=0.03).

More work is needed to improve outcomes, especially in the pre-hospital setting, Patel noted: “Evidence-based guidelines exist for the pre-hospital treatment of seizures and most emergency medical services have independent protocols, but it is not known if these guidelines are implemented uniformly by emergency medical services personnel.

“Standardization of these protocols using guidelines may improve outcomes and is a good first step.”

The study has several limitations, the researchers noted. They did not determine the association between the dose of benzodiazepine and outcomes, and the small number of overall deaths in the study limited the number of confounders in the analysis; other confounders may have influenced mortality and other outcomes. In the pre-hospital setting, times to treatment were based on information provided by families, although the researchers corroborated data with emergency medical services reports and medical records when available.

In addition, the team said, the findings do not include patients whose seizures spontaneously stopped, or stopped after medication before coming to the hospital; the findings apply only to pediatric patients with refractory convulsive SE.

The study and the Pediatric Status Epilepticus Research Group consortium of 11 tertiary pediatric hospitals in the United States are funded by the Epilepsy Research Fund and the Pediatric Epilepsy Research Foundation.

The researchers reported financial relationships with Ovation Pharmaceuticals, King Pharmaceuticals, PRA International/Eisai, Johnson & Johnson, Lily, GlaxoSmithKline, Pfizer, Siemens, General Electric, Supernus, AssureX Health, Sage Therapeutics, GWPharm, Novartis, Lundbeck, Upsher-Smith, Acorda, and Zogenix.

Patel reported financial relationships with Greenwich Biosciences, UCB Pharma, Supernus, LivaNova, and Upsher-Smith.

2018-01-23T14:00:00-0500

Tagged with:

About author

Related Articles